and operational barriers. The company provides support across early-stage clinical trials, regulatory strategy, non-clinical research, bioanalytical services, CMC, trial IP manufacturing, and clinical development planning.

iNGENū CRO helps sponsors conduct cost-effective clinical trials in Australia and the Asia-Pacific region while maintaining high standards of quality, compliance, and operational execution. Its services are designed to support streamlined clinical trial start-up, FDA-compliant data generation, and global regulatory pathways, including U.S. FDA submissions.

The company works with biotech sponsors across a wide range of therapeutic areas, including oncology, rare and orphan diseases, neuroscience, psychiatry, cardiovascular, respiratory medicine, dermatology, rheumatology, infectious diseases, gastroenterology, anaesthesia and pain medicine, cannabinoid and psychedelic research, cell and gene therapy, and other specialty areas.

iNGENū CRO’s mission is to create global access to high-quality clinical research for early to mid-stage biotech companies by combining physician-led expertise, scientific knowledge, regulatory experience, operational support, and long-term sponsor partnerships.